Cwm LLC Buys 43,103 Shares of Cabot Corporation $CBT

Cwm LLC boosted its holdings in shares of Cabot Corporation (NYSE:CBT) by 7,183.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 43,703 shares of the specialty chemicals company’s stock after purchasing an additional 43,103 shares during the period. Cwm LLC owned about 0.08% of Cabot worth $3,278,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. lifted its stake in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the period. Banque Cantonale Vaudoise bought a new position in Cabot during the first quarter worth about $43,000. UMB Bank n.a. lifted its stake in Cabot by 52.4% during the second quarter. UMB Bank n.a. now owns 730 shares of the specialty chemicals company’s stock worth $55,000 after purchasing an additional 251 shares during the period. Brooklyn Investment Group lifted its stake in Cabot by 1,553.7% during the first quarter. Brooklyn Investment Group now owns 678 shares of the specialty chemicals company’s stock worth $56,000 after purchasing an additional 637 shares during the period. Finally, NewEdge Advisors LLC lifted its stake in Cabot by 2,559.5% during the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after purchasing an additional 947 shares during the period. Institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

Shares of Cabot stock opened at $69.62 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.13 and a quick ratio of 1.41. The firm has a market cap of $3.70 billion, a P/E ratio of 9.10 and a beta of 0.88. The firm has a 50 day simple moving average of $77.29 and a 200 day simple moving average of $76.73. Cabot Corporation has a fifty-two week low of $66.50 and a fifty-two week high of $117.46.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. The business had revenue of $923.00 million during the quarter, compared to analyst estimates of $957.29 million. Cabot had a net margin of 11.14% and a return on equity of 25.68%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. Sell-side analysts predict that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Insider Buying and Selling at Cabot

In related news, CEO Sean D. Keohane sold 114,436 shares of the firm’s stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total value of $9,072,486.08. Following the completion of the sale, the chief executive officer owned 361,518 shares of the company’s stock, valued at $28,661,147.04. This trade represents a 24.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 3.03% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

CBT has been the subject of a number of analyst reports. UBS Group set a $82.00 price target on shares of Cabot and gave the stock a “neutral” rating in a research note on Tuesday, August 5th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research note on Wednesday, October 8th. Finally, Mizuho dropped their price objective on shares of Cabot from $90.00 to $88.00 and set an “outperform” rating for the company in a report on Friday, October 3rd. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $85.00.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.